+Vote!
Earn More Money (Free subscription) | yesterday
Here is the package deal we're running for this week Currently in Practice: Medical Doctors in America 788,245 in total * 17,474 emails Coverage in many different areas of medicine such as Endocrinology, Pathology, Urology, Neurology, Plastic Surgery, Psychiatry, Cardiology and much more 16 different sortable fields Database of American Pharma Companies 47,000 personal emails and names of decision...
+Vote!
Medical News Today (Free subscription) | yesterday
Serdar Tegkul, MD, Committee Chair PARIS, FRANCE (UroToday.com) - Dr. Tegkul began by noting the difficulties in producing Level 1 data for the pediatric population, as it is very difficult to recruit for randomized controlled trials. He reviewed the International Children's Continence Society's definition of pediatric incontinence, which is the "involuntary loss of urine at inappropriate and socially...
+Vote!
Medical News Today (Free subscription) | yesterday
Karl-Erik Andersson, MD, PhD, and Christopher Chapple, MD, Committee Chairs PARIS, FRANCE (UroToday.com) - Dr. Andersson began this presentation with a brief overview of the updated 2002 ICS definitions regarding lower urinary tract function and OAB and proposed theories for the pathophysiology of OAB.
+Vote!
Medical News Today (Free subscription) | 23/07/2008
Mark Mulac was once an "avid lover" of iced tea, downing up to six glasses a day of the popular summertime thirst-quencher. "I was a junkie on a bender. I had to have it every day," said Mulac, a resident of Brookfield, Ill. "Iced tea was very refreshing, cheap to buy and easy to make." Unfortunately, Mulac was forced to go cold turkey. Iced tea helped to bring on an excruciating bout of kidney stones...
+Vote!
Medical News Today (Free subscription) | 23/07/2008
Hyperion Therapeutics, Inc. announced that it has completed patient enrollment in its Phase 1/2 clinical trial to evaluate the safety, tolerability and ammonia scavenging effects of HPN-100 (formally called GT4P) versus BUPHENYL(R) (sodium phenylbutyrate) in patients with urea cycle disorders (UCD). The company plans to announce top-line results in the fourth quarter of this year.
+Vote!
EuroInvestor.co.uk (Free subscription) | 21/07/2008
HealthTronics, Inc. (NASDAQ: HTRN), a leading provider of urology services and products, today announced that it has acquired UroPath, LLC ( “ UroPath Read more
+Vote!
The Earth Times Online Newspaper (Free subscription) | 21/07/2008
AUSTIN, Texas - HealthTronics, Inc. (NASDAQ: HTRN), a leading provider of urology services and products, today announced that it has acquired UroPath, LLC (“UroPath”) for $7.5 million. Founded in 2003, U
+Vote!
Medical News Today (Free subscription) | 20/07/2008
Elsevier, a leading publisher of scientific, technical and medical information, announced that European Urology, the official journal of the European Association of Urology (EAU), has a newly released impact factor of 5.634. European Urology (also the "Platinum Journal") offers its readers and authors high quality papers, fast response and an international profile.
+Vote!
Medical News Today (Free subscription) | 19/07/2008
The European Association of Urology (EAU) launched a new website recently as platform for the promotional activities for the first European Urology Week, which will be organised from 15 to 19 September. www.urologyweek.org is a general public-oriented site which should provide people with information about urological conditions and when to seek help from a urologist.
+Vote!
Medical News Today (Free subscription) | 16/07/2008
US researchers say that kidney stones may become more common as the temperature rises across North America and causes more people to become dehydrated. The study is the work of researchers at the University of Texas (UT) Southwestern Medical Center at Dallas, and is published in the 15th July issue of the Proceedings of the National Academy of Sciences (PNAS).
1Vote!
Love Global Warming (Free subscription) | 15/07/2008
Further evidence that global warming, (alias: climate change) resulting from the excesses of Western Civilization either causes or makes worse everything bad under the sun. Margaret Pearle, professor of urology at University of Texas Southwestern asserts that global warming may increase kidney stones : More Americans are likely to suffer from kidney stones in the coming years as a result of global...
+Vote!
Medical News Today (Free subscription) | 15/07/2008
Amgen (NASDAQ: AMGN) announced findings from a three-year pivotal Phase 3 placebo-controlled trial evaluating denosumab in the treatment of bone loss in men undergoing androgen deprivation therapy (ADT) for non-metastatic prostate cancer.
+Vote!
Nimisis.com (Free subscription) | 15/07/2008
Here's a little plug for my godfather's charity - UCARE (Urology Cancer Research and Education) supports cancer research projects in Oxford that are taking a leading role in fighting cancer . Urological cancers represent nearly 20% of all cancers diagnosed in the UK each year. Your support will make a difference! Tags: cancer , medicine
+Vote!
Medical News Today (Free subscription) | 14/07/2008
Theragenics Corporation, a medical device Company serving the prostate cancer and surgical markets (NYSE: TGX), is challenging men to engage in a national debate surrounding the treatment of the disease that will affect one in six of them - prostate cancer. This week, the Company announced its latest campaign to promote awareness of proven prostate cancer treatment options, "The Great Prostate Debate....
+Vote!
Medical News Today (Free subscription) | 14/07/2008
Affymax, Inc. (Nasdaq:AFFY) announced that enrollment has been completed in the first of four Phase 3 clinical trials of its lead investigational therapy, Hematide™, which is being evaluated for the treatment of anemia in chronic renal failure patients. PEARL 1 (Phase 3 Evaluation of Hematide for Anemia Correction in Chronic Renal Failure) is fully enrolled with over 475 non-dialysis patients from...
